Market Tracker

09/17 3:20am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.04
Data as of Sep 16
 +0.05 / +0.56%
Today’s Change
6.88
Today|||52-Week Range
18.18
-39.69%
Year-to-Date

Today’s Trading

Previous close8.99
Today’s open8.94
Day’s range8.75 - 9.11
Volume1,305,839
Average volume (3 months)1,294,477
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/16/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.02-0.44%
KITEKite Pharma Inc+0.47+1.78%
BLUEbluebird bio Inc+1.14+3.32%
OPHTOphthotech Corp+0.28+0.72%
Data as of 3:59pm ET, 09/16/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts